SAN FRANCISCO, Oct. 16, 2024 /PRNewswire/ -- Percheron Capital ("Percheron ... Lundy has joined the firm as a Managing Director and Head of Investor Relations to lead the firm's investor ...
Lundy had also served as managing director and head of investor relations at Lindsay Goldberg in New York Based in San Francisco, Percheron Capital invests in essential services businesses ...
Megan Lundy has joined $3 billion Percheron Capital as a managing director and first head of investor relations, a Percheron spokesperson said. In the new position, Lundy will lead Percheron’s ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
stockhead on MSN16d
Dr Boreham’s Crucible: Does this biotech have the horsepower to become ‘the next Neuren’?Percheron on Friday emerged from Wednesday’s capital raising trading halt with a two-tranche $13 million placement at 8.0 ...
Percheron Therapeutics (AU:PER) has released an update. Percheron Therapeutics Limited has announced the quotation of 135,231,746 ordinary fully paid securities on the Australian Securities ...
Percheron Therapeutics (AU:PER) has released an update. Percheron Therapeutics Limited has announced plans to issue up to 25 million ordinary fully paid securities under a securities purchase plan ...
Percheron Therapeutics (AU:PER) has released an update. Percheron Therapeutics has convened international advisory boards with top specialists to discuss the potential of its novel drug, avicursen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback